Fauci, A.S., Harley, J.B., Roberts, W.C., Ferrans, V.J., Gralnick, H.R. and Bjornson, B.H. (1982) The Idiopathic Hypereosinophilic Syndrome. Clinical, Pathophysiologic, and Therapeutic Considerations. Annals of Internal Medicine, 97, 78-92.
https://doi.org/10.7326/0003-4819-97-1-78

has been cited by the following article:

• TITLE: A Fatal Case of Chronic Eosinophilic Leukemia Not Otherwise Specified (CEL-NOS) in a 19-Year-Old Male with Acute Transformation into Blast Crisis

  AUTHORS: Basheer Al-Sanouri, Basheer Al-Sanouri, Yahya Maslamani, Ibrahim Al-Sanouri

  KEYWORDS: Hypereosinophilic Syndrome (HES), Eosinophils Degranulation, WHO World Health Organization Classification, Chronic Eosinophilic Leukemia Not Other-wise Specified (CEL-NOS), Fluorescent In Situ Hybridization (FISH), Tyrosine Kinase Inhibitor Imatinib, Acute Transformation into Blast Crisis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.5 No.12, December 22, 2016

  ABSTRACT: Chronic eosinophilic leukemia (CEL) is a rare disorder that is characterized by hypereosinophilia with increased number of blood or marrow blasts (>5% and